Vertex Pharmaceuticals Incorporated
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| VRTX.VI | 095700.KQ | CSL.AX | KRYS | ROIV | 1530.HK | |
|---|---|---|---|---|---|---|
| Market cap | 124.39B | 94.14B | 97.13B | 9.21B | 27.61B | 37.99B |
| P/E (TTM) | 36.7 | — | — | 42.2 | — | 4.1 |
| Forward P/E | — | — | 21.5 | 34.0 | -27.5 | 11.2 |
| Price/book | 6.7 | — | 4.6 | 6.4 | 6.5 | 1.2 |
| Dividend yield | — | — | 2.05% | — | — | 1.69% |
| 1-year change | +29.76% | −60.56% | +11.91% | +55.44% | +85.85% | −51.32% |
| Today | +1.73% | +0.73% | +2.56% | +1.90% | +6.08% | +4.00% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All VRTX.VI news ›Vertex Pharmaceuticals Q3 2026 Earnings Preview
Preview Vertex Pharmaceuticals Q3 earnings: EPS and revenue estimates, revision trends, and beat history ahead of Monday's after-hours report. - Vertex Pharmaceuticals (VRTX) is scheduled to announce Q3 earnings results on Monday, November…
Vertex Pharmaceuticals (VRTX) Set to Report Q3 Earnings on November 2
On November 01, 2026, Vertex Pharmaceuticals Inc VRTX is scheduled to release its Q3 earnings after market close. Investors and analysts will be closely watching the company’s performance amid mixed recent estimate revisions and a strong…
Vertex Pharmaceuticals Incorporated $VRTX Stock Sold by Sumitomo Mitsui Trust Group Inc.
Posted by Mitch Edgeman on Nov 1st, 2026 Read Our Latest Stock Report on Vertex Pharmaceuticals Vertex Pharmaceuticals Incorporated is a global biotechnology company focused on developing and commercializing medicines for serious diseases.…
Vertex Pharmaceuticals (NASDAQ:VRTX) Downgraded by Wall Street Zen to Hold
Posted by Tristan Rich on Nov 1st, 2026 Wall Street Zen lowered shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) from a buy rating to a hold rating in a research report released on Saturday morning,Wall Street Zen reports. Get…
Analysts Are Bullish on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Oxford BioMedica (OXBDF)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Oxford BioMedica (OXBDF) with bullish sentiments. In a report released today, Phil Nadeau from TD Cowen…
Vertex Pharmaceuticals (NASDAQ:VRTX) Beats Q1 CY2026 Sales Expectations
Biotech company Vertex Pharmaceuticals (NASDAQ:VRTX) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 7.8% year on year to $2.99 billion. The company expects the full year’s revenue to be around $13.03 billion, close to…
Why Vertex Pharmaceuticals (VRTX) Stock Is Up Today
Vertex Pharmaceuticals (VRTX) is up 3.3% today. Here is some analysis on what might have caused this price movement. Analysis: The move appears tied to growing optimism around Vertex’s kidney disease program and a near-term catalyst…
Vertex Pharmaceuticals Reaches $558.88, a Fresh 52-Week Peak
As seen on the 24/7 Wall St. homepage on October 30, 2026. Vertex Pharmaceuticals closed at $558.88, a fresh 52-week high and 0.16% above the September 3 peak. The $141.7 billion biotech has now reclaimed the top of its range after a…
Reviewing BioLineRx (NASDAQ:BLRX) and Vertex Pharmaceuticals (NASDAQ:VRTX)
Posted by Danessa Lincoln on Oct 30th, 2026 BioLineRx (NASDAQ:BLRX – Get Free Report) and Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two…
Vertex kidney disease drug scrutinized for infection risk
Adam Feuerstein is a senior writer and biotech columnist for STAT, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a cohost of STAT's weekly "The Readout LOUD" podcast and the author of…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com18
- fool.com8
- stocktitan.net6
- theglobeandmail.com6
- defenseworld.net5
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 92 articles, not a forecast.